vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and HANMI FINANCIAL CORP (HAFC). Click either name above to swap in a different company.
BillionToOne, Inc. is the larger business by last-quarter revenue ($83.5M vs $71.2M, roughly 1.2× HANMI FINANCIAL CORP). HANMI FINANCIAL CORP runs the higher net margin — 29.8% vs 6.8%, a 23.0% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 17.1%). HANMI FINANCIAL CORP produced more free cash flow last quarter ($203.7M vs $6.5M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
Hanmi Bank Corporation is a community bank headquartered in Los Angeles, California, with 35 branches and eight loan production offices in California, Texas, Illinois, New York, New Jersey and Virginia.
BLLN vs HAFC — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $71.2M |
| Net Profit | $5.7M | $21.2M |
| Gross Margin | 69.9% | — |
| Operating Margin | 11.5% | 29.8% |
| Net Margin | 6.8% | 29.8% |
| Revenue YoY | 117.4% | 17.1% |
| Net Profit YoY | 138.3% | 20.0% |
| EPS (diluted) | $0.10 | $0.70 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $71.2M | ||
| Q3 25 | $83.5M | $71.0M | ||
| Q2 25 | — | $65.2M | ||
| Q1 25 | — | $62.8M | ||
| Q4 24 | — | $60.8M | ||
| Q3 24 | $38.4M | $58.5M | ||
| Q2 24 | — | $56.7M | ||
| Q1 24 | — | $58.4M |
| Q4 25 | — | $21.2M | ||
| Q3 25 | $5.7M | $22.1M | ||
| Q2 25 | — | $15.1M | ||
| Q1 25 | — | $17.7M | ||
| Q4 24 | — | $17.7M | ||
| Q3 24 | $-14.9M | $14.9M | ||
| Q2 24 | — | $14.5M | ||
| Q1 24 | — | $15.2M |
| Q4 25 | — | — | ||
| Q3 25 | 69.9% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 52.6% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 29.8% | ||
| Q3 25 | 11.5% | 31.1% | ||
| Q2 25 | — | 23.2% | ||
| Q1 25 | — | 28.1% | ||
| Q4 24 | — | 29.1% | ||
| Q3 24 | -32.9% | 25.5% | ||
| Q2 24 | — | 25.5% | ||
| Q1 24 | — | 26.0% |
| Q4 25 | — | 29.8% | ||
| Q3 25 | 6.8% | 31.1% | ||
| Q2 25 | — | 23.2% | ||
| Q1 25 | — | 28.1% | ||
| Q4 24 | — | 29.1% | ||
| Q3 24 | -38.8% | 25.5% | ||
| Q2 24 | — | 25.5% | ||
| Q1 24 | — | 26.0% |
| Q4 25 | — | $0.70 | ||
| Q3 25 | $0.10 | $0.73 | ||
| Q2 25 | — | $0.50 | ||
| Q1 25 | — | $0.58 | ||
| Q4 24 | — | $0.58 | ||
| Q3 24 | $-1.47 | $0.49 | ||
| Q2 24 | — | $0.48 | ||
| Q1 24 | — | $0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | — |
| Total DebtLower is stronger | $55.0M | — |
| Stockholders' EquityBook value | $-239.5M | $796.4M |
| Total Assets | $327.5M | $7.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $195.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $796.4M | ||
| Q3 25 | $-239.5M | $779.5M | ||
| Q2 25 | — | $762.8M | ||
| Q1 25 | — | $751.5M | ||
| Q4 24 | — | $732.2M | ||
| Q3 24 | $-242.9M | $736.7M | ||
| Q2 24 | — | $707.1M | ||
| Q1 24 | — | $703.1M |
| Q4 25 | — | $7.9B | ||
| Q3 25 | $327.5M | $7.9B | ||
| Q2 25 | — | $7.9B | ||
| Q1 25 | — | $7.7B | ||
| Q4 24 | — | $7.7B | ||
| Q3 24 | — | $7.7B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $7.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $206.0M |
| Free Cash FlowOCF − Capex | $6.5M | $203.7M |
| FCF MarginFCF / Revenue | 7.7% | 286.2% |
| Capex IntensityCapex / Revenue | 8.8% | 3.2% |
| Cash ConversionOCF / Net Profit | 2.42× | 9.70× |
| TTM Free Cash FlowTrailing 4 quarters | — | $356.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $206.0M | ||
| Q3 25 | $13.8M | $146.9M | ||
| Q2 25 | — | $-19.0M | ||
| Q1 25 | — | $25.8M | ||
| Q4 24 | — | $52.6M | ||
| Q3 24 | — | $6.7M | ||
| Q2 24 | — | $2.1M | ||
| Q1 24 | — | $30.0M |
| Q4 25 | — | $203.7M | ||
| Q3 25 | $6.5M | $146.4M | ||
| Q2 25 | — | $-19.6M | ||
| Q1 25 | — | $25.6M | ||
| Q4 24 | — | $49.9M | ||
| Q3 24 | — | $6.5M | ||
| Q2 24 | — | $1.3M | ||
| Q1 24 | — | $29.2M |
| Q4 25 | — | 286.2% | ||
| Q3 25 | 7.7% | 206.3% | ||
| Q2 25 | — | -30.0% | ||
| Q1 25 | — | 40.7% | ||
| Q4 24 | — | 82.1% | ||
| Q3 24 | — | 11.1% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | 50.0% |
| Q4 25 | — | 3.2% | ||
| Q3 25 | 8.8% | 0.8% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 4.3% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | 1.4% |
| Q4 25 | — | 9.70× | ||
| Q3 25 | 2.42× | 6.66× | ||
| Q2 25 | — | -1.26× | ||
| Q1 25 | — | 1.46× | ||
| Q4 24 | — | 2.97× | ||
| Q3 24 | — | 0.45× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 1.98× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
HAFC
Segment breakdown not available.
